G protein-coupled estrogen receptor 1-mediated effects in the rat myometrium

American Journal of Physiology - Cell Physiology

Volumn 301, Issue 5, 2011, Pages

  Tica, Andrei A ^a   Dun, Erica C ^b   Tica, Oana S ^a   Gao, Xin ^a   Arterburn, Jeffrey B ^c   Brailoiu, G Cristina ^a   Oprea, Tudor I ^d,e   Brailoiu, Eugen ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NEW MEXICO STATE UNIVERSITY   (United States)

^d UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^e Sunset Molecular Discovery LLC   (United States)

Author keywords

Calcium imaging; Membrane potential; Uterine contractility

Indexed keywords

G PROTEIN COUPLED RECEPTOR 30; NIFEDIPINE; THAPSIGARGIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DEPOLARIZATION; FEMALE; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; MEMBRANE POTENTIAL; MYOMETRIUM; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UTERUS CONTRACTILITY;

ANIMALS; BENZODIOXOLES; CALCIUM; CALCIUM CHANNEL BLOCKERS; CYCLOPENTANES; ENZYME INHIBITORS; FEMALE; MEMBRANE POTENTIALS; MYOMETRIUM; NIFEDIPINE; QUINOLINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, G-PROTEIN-COUPLED; THAPSIGARGIN; UTERINE CONTRACTION;

RATTUS;

EID: 80054958415     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00501.2010     Document Type: Article

References (50)

1. Albanito L, Lappano R, Madeo A, Chimento A, Prossnitz ER, Cappello AR, Dolce V, Abonante S, Pezzi V, Maggiolini M. G-proteincoupled receptor 30 and estrogen receptor-alpha are involved in the proliferative effects induced by atrazine in ovarian cancer cells. Environ Health Perspect 116: 1648-1655, 2008.
2. Ariazi EA, Brailoiu E, Yerrum S, Shupp HA, Slifker MJ, Cunliffe HE, Black MA, Donato AL, Arterburn JB, Oprea TI, Prossnitz ER, Dun NJ, Jordan VC. The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells. Cancer Res 70: 1184-1194, 2010.
3. Babich LG, Ku CY, Young HW, Huang H, Blackburn MR, Sanborn BM. Expression of capacitative calcium TrpC proteins in rat myometrium during pregnancy. Biol Reprod 70: 919-924, 2004.
4. Bologa CG, Revankar CM, Young SM, Edwards BS, Arterburn JB, Kiselyov AS, Parker MA, Tkachenko SE, Savchuck NP, Sklar LA, Oprea TI, Prossnitz ER. Virtual and biomolecular screening converge on a selective agonist for GPR30. Nat Chem Biol 2: 207-212, 2006.
5. Brailoiu E, Dun SL, Brailoiu GC, Mizuo K, Sklar LA, Oprea TI, Prossnitz ER, Dun NJ. Distribution and characterization of estrogen receptor G protein-coupled receptor 30 in the rat central nervous system. J Endocrinol 193: 311-321, 2007.
6. Brailoiu E, Filipeanu CM, Tica A, Toma CP, de Zeeuw D, Nelemans SA. Contractile effects by intracellular angiotensin II via receptors with a distinct pharmacological profile in rat aorta. Br J Pharmacol 126: 1133-1138, 1999.
7. Brailoiu E, Hooper R, Cai X, Brailoiu GC, Keebler MV, Dun NJ, Marchant JS, Patel S. An ancestral deuterostome family of two-pore channels mediates nicotinic acid adenine dinucleotide phosphate-dependent calcium release from acidic organelles. J Biol Chem 285: 2897-2901, 2010.
8. Brailoiu GC, Brailoiu E, Chang JK, Dun NJ. Excitatory effects of human immunodeficiency virus 1 Tat on cultured rat cerebral cortical neurons. Neuroscience 151: 701-710, 2008.
9. Brailoiu GC, Gurzu B, Gao X, Parkesh R, Aley PK, Trifa DI, Galione A, Dun NJ, Madesh M, Patel S, Churchill GC, Brailoiu E. Acidic NAADP-sensitive calcium stores in the endothelium: agonist-specific recruitment and role in regulating blood pressure. J Biol Chem 285: 37133-37137, 2010.
10. Brailoiu GC, Oprea TI, Zhao P, Abood ME, Brailoiu E. Intracellular CB1 cannabinoid receptors are activated by anandamide. J Biol Chem 86: 29166-29174, 2011.
11. Brauner T, Hulser DF, Strasser RJ. Comparative measurements of membrane potentials with microelectrodes and voltage-sensitive dyes. Biochim Biophys Acta 771: 208-216, 1984.
12. Cheng SB, Graeber CT, Quinn JA, Filardo EJ. Retrograde transport of the transmembrane estrogen receptor, G-protein-coupled-receptor-30 (GPR30/GPER) from the plasma membrane towards the nucleus. Steroids 76: 892-896, 2011.
13. Deliu E, Tica AA, Motoc D, Brailoiu GC, Brailoiu E. Intracellular angiotensin II activates rat myometrium. Am J Physiol Cell Physiol 301: C559-C565, 2011.
14. Dennis MK, Burai R, Ramesh C, Petrie WK, Alcon SN, Nayak TK, Bologa CG, Leitao A, Brailoiu E, Deliu E, Dun NJ, Sklar LA, Hathaway HJ, Arterburn JB, Oprea TI, Prossnitz ER. In vivo effects of a GPR30 antagonist. Nat Chem Biol 5: 421-427, 2009.
15. Ebner TJ, Chen G. Use of voltage-sensitive dyes and optical recordings in the central nervous system. Prog Neurobiol 46: 463-506, 1995.
16. Filardo E, Quinn J, Pang Y, Graeber C, Shaw S, Dong J, Thomas P. Activation of the novel estrogen receptor G protein-coupled receptor 30 (GPR30) at the plasma membrane. Endocrinology 148: 3236-3245, 2007.
17. Filardo EJ. Epidermal growth factor receptor (EGFR) transactivation by estrogen via the G-protein-coupled receptor, GPR30: a novel signaling pathway with potential significance for breast cancer. J Steroid Biochem Mol Biol 80: 231-238, 2002.
18. Filardo EJ, Quinn JA, Frackelton AR Jr, Bland KI. Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptorto- MAPK signaling axis. Mol Endocrinol 16: 70-84, 2002.
19. Funakoshi T, Yanai A, Shinoda K, Kawano MM, Mizukami Y. G protein-coupled receptor 30 is an estrogen receptor in the plasma membrane. Biochem Biophys Res Commun 346: 904-910, 2006.
20. Gao F, Ma X, Ostmann AB, Das SK. GPR30 activation opposes estrogen-dependent uterine growth via inhibition of stromal ERK1/2 and estrogen receptor alpha (ERα) phosphorylation signals. Endocrinology 152: 1434-1447, 2011.
21. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260: 3440-3450, 1985.
22. 2+ entry induced by cyclic ADP-ribose in intact T-lymphocytes. J Biol Chem 272: 8546-8550, 1997.
23. Huang GS, Gunter MJ, Arend RC, Li M, Arias-Pulido H, Prossnitz ER, Goldberg GL, Smith HO. Co-expression of GPR30 and ERbeta and their association with disease progression in uterine carcinosarcoma. Am J Obstet Gynecol 203: 242 e241-e245, 2010.
24. Ignatov T, Eggemann H, Semczuk A, Smith B, Bischoff J, Roessner A, Costa SD, Kalinski T, Ignatov A. Role of GPR30 in endometrial pathology after tamoxifen for breast cancer. Am J Obstet Gynecol 203: 595 e599-e516, 2010.
25. Isensee J, Meoli L, Zazzu V, Nabzdyk C, Witt H, Soewarto D, Effertz K, Fuchs H, Gailus-Durner V, Busch D, Adler T, de Angelis MH, Irgang M, Otto C, Noppinger PR. Expression pattern of G proteincoupled receptor 30 in LacZ reporter mice. Endocrinology 150: 1722-1730, 2009.
26. Krizsan-Agbas D, Pedchenko T, Smith PG. Neurotrimin is an estrogenregulated determinant of peripheral sympathetic innervation. J Neurosci Res 86: 3086-3095, 2008.
27. Kuriyama H, Suzuki H. Changes in electrical properties of rat myometrium during gestation and following hormonal treatments. J Physiol 260: 315-333, 1976.
28. Maiti K, Paul JW, Read M, Chan EC, Riley SC, Nahar P, Smith R. G-1-activated membrane estrogen receptors mediate increased contractility of the human myometrium. Endocrinology 152: 2448-2455, 2011.
29. Mizukami Y. In vivo functions of GPR30/GPER-1, a membrane receptor for estrogen: from discovery to functions in vivo. Endocr J 57: 101-107, 2010.
30. Mueller A, Siemer J, Schreiner S, Koesztner H, Hoffmann I, Binder H, Beckmann MW, Dittrich R. Role of estrogen and progesterone in the regulation of uterine peristalsis: results from perfused non-pregnant swine uteri. Hum Reprod 21: 1863-1868, 2006.
31. Olde B, Leeb-Lundberg LM. GPR30/GPER1: searching for a role in estrogen physiology. Trends Endocrinol Metab 20: 409-416, 2009.
32. Otto C, Fuchs I, Kauselmann G, Kern H, Zevnik B, Andreasen P, Schwarz G, Altmann H, Klewer M, Schoor M, Vonk R, Fritzemeier KH. GPR30 does not mediate estrogenic responses in reproductive organs in mice. Biol Reprod 80: 34-41, 2009.
33. Otto C, Rohde-Schulz B, Schwarz G, Fuchs I, Klewer M, Brittain D, Langer G, Bader B, Prelle K, Nubbemeyer R, Fritzemeier KH. G protein-coupled receptor 30 localizes to the endoplasmic reticulum and is not activated by estradiol. Endocrinology 149: 4846-4856, 2008.
34. Perusquia M. Nongenomic action of steroids in myometrial contractility. Endocrine 15: 63-72, 2001.
35. Prossnitz ER, Arterburn JB, Smith HO, Oprea TI, Sklar LA, Hathaway HJ. Estrogen signaling through the transmembrane G protein-coupled receptor GPR30. Annu Rev Physiol 70: 165-190, 2008.
36. Putney JW. The physiological function of store-operated calcium entry. Neurochem Res 36: 1157-1165, 2011.
37. Re RN. The lysosomal action of intracrine angiotensin II. Focus on ''Intracellular angiotensin II activates rat myometrium''. Am J Physiol Cell Physiol 301: C553-C554, 2011.
38. Re RN, Cook JL. Mechanisms of disease: intracrine physiology in the cardiovascular system. Nat Clin Pract Cardiovasc Med 4: 549-557, 2007.
39. Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307: 1625-1630, 2005.
40. Richter ON, Bartz C, Dowaji J, Kupka M, Reinsberg J, Ulrich U, Rath W. Contractile reactivity of human myometrium in isolated nonpregnant uteri. Hum Reprod 21: 36-45, 2006.
41. Sakamoto H, Matsuda K, Hosokawa K, Nishi M, Morris JF, Prossnitz ER, Kawata M. Expression of G protein-coupled receptor-30, a G protein-coupled membrane estrogen receptor, in oxytocin neurons of the rat paraventricular and supraoptic nuclei. Endocrinology 148: 5842-5850, 2007.
42. Shintani Y, Hirano K, Nakayama T, Nishimura J, Nakano H, Kanaide H. Mechanism of trypsin-induced contraction in the rat myometrium: the possible involvement of a novel member of protease-activated receptor. Br J Pharmacol 133: 1276-1285, 2001.
43. Smith HO, Leslie KK, Singh M, Qualls CR, Revankar CM, Joste NE, Prossnitz ER. GPR30: a novel indicator of poor survival for endometrial carcinoma. Am J Obstet Gynecol 196: 386 e381-e389; discussion 386 e389-e311, 2007.
44. Thomas P, Pang Y, Filardo EJ, Dong J. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 146: 624-632, 2005.
45. Vivacqua A, Bonofiglio D, Recchia AG, Musti AM, Picard D, Ando S, Maggiolini M. The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells. Mol Endocrinol 20: 631-646, 2006.
46. Wang A, Ji L, Shang W, Li M, Chen L, White RE, Han G. Expression of GPR30, ERalpha and ERbeta in endometrium during window of implantation in patients with polycystic ovary syndrome: a pilot study. Gynecol Endocrinol 27: 251-255, 2011.
47. Wang C, Prossnitz ER, Roy SK. G protein-coupled receptor 30 expression is required for estrogen stimulation of primordial follicle formation in the hamster ovary. Endocrinology 149: 4452-4461, 2008.
48. Willenburg KL, Knox RV, Kirkwood RN. Effect of estrogen formulation and its site of deposition on serum PGFM concentrations, uterine contractility, and time of ovulation in artificially inseminated weaned sows. Anim Reprod Sci 80: 147-156, 2004.
49. Wray S, Kupittayanant S, Shmygol A, Smith RD, Burdyga T. The physiological basis of uterine contractility: a short review. Exp Physiol 86: 239-246, 2001.
50. Yang M, Gupta A, Shlykov SG, Corrigan R, Tsujimoto S, Sanborn BM. Multiple Trp isoforms implicated in capacitative calcium entry are expressed in human pregnant myometrium and myometrial cells. Biol Reprod 67: 988-994, 2002.